P248âSubcutaneous secukinumab 150 mg provides rapid and sustained relief in total and nocturnal back pain, morning stiffness and fatigue in patients with active AS over 4 years
Marzo-Ortega, Helena, Miceli-Richard, Corinne, Gill, Sonja, Magery, Marina, Machado, Paula G. P, Shete, Abhijit, Wang, Jianyuan, Rohrer, Susanne, Deodhar, AtulVolume:
59
Journal:
Rheumatology
DOI:
10.1093/rheumatology/keaa111.241
Date:
April, 2020
File:
PDF, 63 KB
2020